Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yunnan Menghai Tea Factory is a prestigious Chinese tea producer and a foundational entity in the Pu-erh tea industry, best known for its flagship brand, Dayi (TAETEA). Established in 1940, the factory is historically significant for co-developing the modern ripening (wo dui) fermentation process in the 1970s, which standardized the production of ripe Pu-erh tea. While primarily a consumer goods company, it operates a dedicated Tea Research Institute that conducts biochemical and microbiological studies on tea fermentation and the health-promoting properties of tea polyphenols. The company was privatized in 2004 and now functions as the core manufacturing and research arm of the TAETEA Group. It maintains a dominant market share in the specialty tea sector and is recognized for its standardized tea recipes, such as the 7542 and 7572 blends.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yunnan Menghai Tea Factory.